These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 36036345)
21. Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use. Goodwin RD; Kim JH; Cheslack-Postava K; Weinberger AH; Wu M; Wyka K; Kattan M Addiction; 2021 Oct; 116(10):2770-2778. PubMed ID: 33730400 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on and reanalysis of US National Survey on Drug Use in Households data 2002-2011. Wall MM; Mauro C; Hasin DS; Keyes KM; Cerda M; Martins SS; Feng T Int J Drug Policy; 2016 Mar; 29():9-13. PubMed ID: 26895950 [TBL] [Abstract][Full Text] [Related]
23. Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III). Browne KC; Stohl M; Bohnert KM; Saxon AJ; Fink DS; Olfson M; Cerda M; Sherman S; Gradus JL; Martins SS; Hasin DS Am J Psychiatry; 2022 Jan; 179(1):26-35. PubMed ID: 34407625 [TBL] [Abstract][Full Text] [Related]
24. Severity of DSM-5 cannabis use disorders in a nationally representative sample of sexual minorities. Boyd CJ; Veliz PT; McCabe SE Subst Abus; 2020; 41(2):191-195. PubMed ID: 31638867 [No Abstract] [Full Text] [Related]
25. Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization. Weinberger AH; Zhu J; Levin J; Barrington-Trimis JL; Copeland J; Wyka K; Kim JH; Goodwin RD Drug Alcohol Depend; 2020 Sep; 214():108163. PubMed ID: 32707516 [TBL] [Abstract][Full Text] [Related]
26. Cannabis use disorder and male sex predict medical cannabis card status in a sample of high risk adolescents. Kim J; Coors ME; Young SE; Raymond KM; Hopfer CJ; Wall TL; Corley RP; Brown SA; Sakai JT Drug Alcohol Depend; 2018 Feb; 183():25-33. PubMed ID: 29223914 [TBL] [Abstract][Full Text] [Related]
27. Trends over time in adult cannabis use: A review of recent findings. Hasin D; Walsh C Curr Opin Psychol; 2021 Apr; 38():80-85. PubMed ID: 33873044 [TBL] [Abstract][Full Text] [Related]
28. State-level marijuana policies and marijuana use and marijuana use disorder among a nationally representative sample of adults in the United States, 2015-2017: Sexual identity and gender matter. Philbin MM; Mauro PM; Greene ER; Martins SS Drug Alcohol Depend; 2019 Nov; 204():107506. PubMed ID: 31493750 [TBL] [Abstract][Full Text] [Related]
29. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls]. Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871 [TBL] [Abstract][Full Text] [Related]
30. Assessing the prevalence and risk factors of marijuana use in adults with disabilities. Gimm G; Parekh T; Kitsantas P Addict Behav; 2023 Mar; 138():107559. PubMed ID: 36459827 [TBL] [Abstract][Full Text] [Related]
31. Medical marijuana laws, substance use treatment admissions and the ecological fallacy. Caputi TL Addiction; 2020 Jan; 115(1):188-189. PubMed ID: 31724211 [No Abstract] [Full Text] [Related]
32. US Epidemiology of Cannabis Use and Associated Problems. Hasin DS Neuropsychopharmacology; 2018 Jan; 43(1):195-212. PubMed ID: 28853439 [TBL] [Abstract][Full Text] [Related]
33. Admissions to substance use treatment facilities for cannabis use disorder, 2000-2017: Does legalization matter? Rhee TG; Rosenheck RA Am J Addict; 2022 Sep; 31(5):423-432. PubMed ID: 35368113 [TBL] [Abstract][Full Text] [Related]
34. The Link Between Marijuana and Hallucinogen Use Among US Adolescents. Desai S; Kulkarni N; Gandhi K; You XX; Gerolemou A Prim Care Companion CNS Disord; 2022 Aug; 24(5):. PubMed ID: 36067501 [No Abstract] [Full Text] [Related]
35. Medical cannabis laws and medical and non-medical prescription stimulant use among a nationally representative sample of US Adults: Examining the role of sexual identity and gender. Philbin MM; Mauro PM; Greene ER; LaBossier NJ; Giovenco DP; Martins SS Int J Drug Policy; 2020 Oct; 84():102861. PubMed ID: 32717704 [TBL] [Abstract][Full Text] [Related]
36. Incidence of Pediatric Cannabis Exposure Among Children and Teenagers Aged 0 to 19 Years Before and After Medical Marijuana Legalization in Massachusetts. Whitehill JM; Harrington C; Lang CJ; Chary M; Bhutta WA; Burns MM JAMA Netw Open; 2019 Aug; 2(8):e199456. PubMed ID: 31418807 [TBL] [Abstract][Full Text] [Related]
37. Preparedness for healthy ageing and polysubstance use in long-term cannabis users: a population-representative longitudinal study. Meier MH; Caspi A; Ambler A; Hariri AR; Harrington H; Hogan S; Houts R; Knodt AR; Ramrakha S; Richmond-Rakerd LS; Poulton R; Moffitt TE Lancet Healthy Longev; 2022 Oct; 3(10):e703-e714. PubMed ID: 36202130 [TBL] [Abstract][Full Text] [Related]
38. Use of marijuana exclusively for medical purposes. Wall MM; Liu J; Hasin DS; Blanco C; Olfson M Drug Alcohol Depend; 2019 Feb; 195():13-15. PubMed ID: 30557813 [TBL] [Abstract][Full Text] [Related]
39. Heterogeneous health effects of medical marijuana legalization: Evidence from young adults in the United States. Chay J; Kim S Health Econ; 2022 Feb; 31(2):269-283. PubMed ID: 34755415 [TBL] [Abstract][Full Text] [Related]
40. Factors associated with the timing and onset of cannabis use and cannabis use disorder: results from the 2007 Australian National Survey of Mental Health and Well-Being. Butterworth P; Slade T; Degenhardt L Drug Alcohol Rev; 2014 Sep; 33(5):555-64. PubMed ID: 25186194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]